
CAS: 1093070-16-6
Ordinare per
4 prodotti.
GRL0617
CAS:GRL0617 is a selective and competitive SARS-CoVPLpro and deubiquitinase noncovalent inhibitor(IC50 : 0.6 μM, Ki : 0.49 μM).Formula:C20H20N2OPurezza:99.31%Colore e forma:SolidPeso molecolare:304.39Ref: TM-T11464
1mg37,00€5mg79,00€10mg111,00€25mg188,00€50mg329,00€100mg527,00€500mg1.121,00€1mL*10mM (DMSO)87,00€Ref: IN-DA01KKBV
1mg189,00€5mg535,00€10mg578,00€25mg647,00€50mgPrezzo su richiesta100mgPrezzo su richiestaGRL 0617
CAS:A novel non-covalent inhibitor of the PLpro protease from SARS-CoV-2 and SARS-CoV viruses. GRL 0617 inhibits the proteolytic processing of the viral polypeptide. As PLpro also acts as a protease in pathways involved in innate immunity, there are indications that it can promote immunity against the virus.Formula:C20H20N2OPurezza:Min. 98 Area-%Colore e forma:PowderPeso molecolare:304.39 g/mol